http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0510044-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8eb0e5ee0f2f935c2e8acb6607c0b3ea |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 2005-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c82f85f7efd520df5c100bc70c40a79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_babe77edfb7566e0012a97d865bcc69e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2b052280aec3700b828766b82fdbc47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a7dd31e5fa97b60eddcfb080180429c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07285a44711b5e3c7b06811d31acfc6d |
| publicationDate | 2007-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI0510044-A |
| titleOfInvention | pharmaceutical composition, kit, method for treating an individual, and use of a first and a second amount of one or more glucocorticoids |
| abstract | PHARMACEUTICAL COMPOSITION, KIT, METHOD FOR TREATING AN INDIVIDUAL, AND USING A FIRST AND SECOND QUANTITY OF ONE OR MORE GLYCORTICOIDS. The invention relates to glucocorticoid replacement therapy and provides pharmaceutical compositions and kits designed to supply one or more glucocorticoids to an individual in need thereof in a manner that results in glucocorticoid serum levels that essentially mimic those of a healthy individual. for a clinically relevant period of time. The pharmaceutical composition comprises one or more glucocorticoids, wherein a first part of one or more glucocorticoids is substantially and immediately released over a prolonged period of at least about 8 hours, and the amount of one or more glucocorticoids of the first part, expressed as hydrocortisone equivalents, is in the range of about 15 to about 50% of the total hydrocortisone equivalents. The invention also relates to a method of treating diseases requiring glucocorticoid treatment, such as in individuals having a glucocorticoid deficiency disorder. In another aspect, the invention relates to the use of a first and a second amount of one or more glucocorticoids for the preparation of a pharmaceutical composition or kit for treating a glucocorticoid deficiency disorder. |
| priorityDate | 2004-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477255 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754 |
Total number of triples: 28.